Material Fact

São Paulo, February 8, 2012 - For compliance with Brazilian Securities Commission (CVM) Instruction 358 dated January 3, 2002, as amended, and the provision under paragraph 4 of article 157 of Brazilian Corporate Law (Law No. 6.404/76, as amended), BRAZIL PHARMA S.A. ("Company"), announces to shareholders and the market that: (i) in a meeting held on February 8, 2012, the board of directors approved the first issuance of simple, unsecured, non-convertible debentures in two series ("Issuance" and "Debentures" respectively), in the amount of up to 25,000 (twenty five thousand) debentures with a nominal unit value of R$10,000.00 (ten thousand reais), totaling in the issuance date (as defined below), up to R$250,000,000.00 (two hundred fifty million reais); (ii) for legal purposes, the Debentures issuance date shall be April 2, 2012 ("Issuance Date"). The first series Debentures shall mature in 4 (four) years as of the Issuance Date, therefore on April 2, 2016. The second series Debentures shall mature in 5 (five) years as of the Issuance Date, therefore on April 2, 2017. The quantity of Debentures in each series shall be defined by the bookbuilding process; (iii) the Issuance shall be subject to public distribution with restricted placement efforts, in accordance with CVM Instruction 476/09, as amended ("Restricted Offer") under the mixed regime of standby underwriting transaction and best efforts; (iv) the proceeds of the Issuance shall be used to new store opening, for the Company's working capital needs and pre-payment of debts; and (v) this material fact is of an exclusively informative nature, in accordance with the prevailing regulation and should not be considered as an offer to sell the Debentures. The minutes of the board of directors' meeting, containing the full approval of the Issuance, is on file at headquarters and in the Company's website (www.brazilpharma.com.br) as well as in the websites of CVM (www.cvm.gov.br) and BM&F BOVESPA S.A. - Brazilian Stock, Commodities and Futures Exchanges (www.bmfbovespa.com.br).

Renato de Vicq Telles da Silva Lobo

Director of Investor Relations

?
distribué par

Ce noodl a été diffusé par Brazil Pharma SA et initialement mise en ligne sur le site http://www.brph.com.br. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-02-09 10:01:14 AM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.